Access cutting-edge hypereosinophilic syndrome treatment through this clinical trial at a research site in Charleston. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Charleston location
Access hypereosinophilic syndrome specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hypereosinophilic syndrome treatment provided free
Check if you qualify for this hypereosinophilic syndrome clinical trial in Charleston, SC
No-Cost Study Care
Local to Charleston
Convenient for SC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a 52-week, randomized, placebo-controlled, double-blind, parallel group, multicenter study of depemokimab in adults with uncontrolled HES receiving standard of care (SoC) therapy. The study will recruit patients with a confirmed diagnosis of HES and who are on stable HES therapy for at least 4 weeks prior to randomization (Visit 2). Eligible participants must have uncontrolled HES with a history of repeated flare (≥2 flares in the previous 12 months) and blood eosinophil count of ≥1,000
Sponsor: GlaxoSmithKline
Yes, this clinical trial (NCT05334368) has an active research site in Charleston, SC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hypereosinophilic syndrome treatment options in Charleston, SC, this clinical trial (NCT05334368) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Charleston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypereosinophilic syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hypereosinophilic syndrome clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Charleston — not just this study.
Browse Pulmonary Embolism Trials in Charleston →